UC San Diego finds genetic switch linking childhood and Alzheimer’s dementia

Researchers at the University of California San Diego have identified a shared cellular mechanism that drives brain degeneration in both a rare childhood disorder and Alzheimer's disease, revealing a potential new avenue for drug development targeting neurodegenerative conditions.

A Common Pathway in Two Diseases

The study, published August 11 in the journal Immunity, shows that a family of proteins known as MITF/TFE act as master genetic switches inside microglia, the brain's dedicated immune cells. When tiny waste-processing structures called lysosomes become overburdened and stressed, these switches flip from "off" to "on," triggering a massive change in the microglia's genetic program. The response, initially protective, eventually becomes maladaptive — fueling inflammation and contributing to the death of neurons.medicalxpress+2

The researchers used a mouse model of Sanfilippo syndrome type A (MPS IIIA), a rare childhood dementia caused by a single gene variant that blocks production of the enzyme sulfamidase. Without the enzyme, cellular debris accumulates, particularly in microglia. The team then found that the same MITF/TFE switches are activated in the microglia of human Alzheimer's patients in response to waste accumulation.today.ucsd+2

"It gave us a really clear framework to study what we see in common neurodegenerative diseases and try to figure out mechanisms that are causing them," said first author Christopher Balak, a postdoctoral researcher in the lab of corresponding author Christopher Glass, professor of cellular and molecular medicine at UC San Diego School of Medicine.today.ucsd

Challenging Conventional Thinking

The findings challenge prevailing assumptions about how neurodegeneration unfolds. Many researchers have believed that amyloid plaques external to microglia cause lysosomes to fail from the "outside in." The new research suggests damage can originate from within the cell itself.technologynetworks+1

"We know lysosomes alone are sufficient to cause neurodegeneration from rare disorders like MPS IIIA. The same thing could be happening in, or at least contributing to, major diseases like Alzheimer's disease," Balak said.today.ucsd

Implications for Treatment

By identifying MITF/TFE proteins as master regulators, the research points to an intracellular drug target distinct from current approaches. "Most microglia-targeted drugs go after receptors on the cell surface," said Balak. "I think this work points to a little bit of a different strategy, instead going after the lysosomal program inside the cell".today.ucsd

The team also found that microglia attempt to minimize damage early before becoming overwhelmed, suggesting that early intervention — before the genetic switch flips immune cells into a harmful state — could prove most effective. However, as the Alzheimer's research forum Alzforum noted, these are companion papers representing early mechanistic work, and the main results were obtained in animal and cell models.iz+3